You just read:

RegeneRx Announces First Patients Enrolled in Phase 3 U.S. Dry Eye Clinical Trial (ARISE-2 Trial) with RGN-259

News provided by

RegeneRx Biopharmaceuticals, Inc.

Nov 09, 2016, 08:26 ET